Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: Prognosis or prediction? Meeting Abstract


Authors: Miller, K.; Krop, I.; Schwartzberg, L.; Abramson, V.; Garcia-Estevez, L.; Eakle, J.; Nanda, R.; Yardley, D.; Ademuyiwa, F.; Chan, S.; Crown, J.; Danso, M.; Gelmon, K.; Ma, L.; Martinez-Janez, N.; Gradishar, W.; Steinberg, J.; Tudor, I. C.; Uppal, H.; Paton, V. E.; Parker, J.; Hudis, C. A.; Traina, T. A.
Abstract Title: Improved clinical outcomes on enzalutamide observed in patients with PREDICT AR+ triple-negative breast cancer: Prognosis or prediction?
Meeting Title: 38th Annual CTRC-AACR San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 76
Issue: 4 Suppl.
Meeting Dates: 2015 Dec 8-12
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2016-02-15
Language: English
ACCESSION: WOS:000375622403020
PROVIDER: wos
DOI: 10.1158/1538-7445.SABCS15-P3-07-25
Notes: Meeting Abstract: P3-07-25 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    905 Hudis
  2. Tiffany A Traina
    250 Traina